| Website | activaero.de |
| Category | BioTech |
| Phone | 49 64 53 64 81 80 |
| info@activaero.de | |
| Employees | |
| Founded | 2004 |
| TOTAL | $22.6M |
| FUNDING TOTAL | $22.6M |
| Series A, 11/09 BioMedPartners VI Partners Abalis Finance Vesalius Biocapital Partners | $15.8M |
| Series A, 2/11 LSP BioVentures BioMedPartners VI Partners Abalis Finance Vesalius Biocapital Partners MedVenture Associates | €5M |
Activaero GmbH, a drug delivery company, engages in the research, development, manufacture, and marketing of controlled breathing technologies that are used for the delivery of inhaled therapeutic agents to the human lung and various lung regions. It offers AKITA, a controlled breathing device with smart card technology for the pulmonary delivery of inhaled therapeutics; and Watchhaler, an inhalation device tailored to the needs of children who need to take inhaled medication. The company also provides AKITA², a controlled breathing technology for the pulmonary delivery of inhaled therapeutics in the clinical trial setting; and LimiX, a first flow limitation valve that controls the flow rate. In addition, it offers measurement and diagnostic technologies for use in laboratory settings, including a system to measure the properties of aerosols in a minute. Further, the company provides contract development services for devices to use in clinical trials; and clinical trial logistics services. It markets its products through distributors. Activaero GmbH was founded in 2004 and is based in Gemunden, Germany. It also has locations in Munich, Germany; and Dublin, Ohio.
